561 related articles for article (PubMed ID: 22613839)
1. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
[TBL] [Abstract][Full Text] [Related]
2. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity induces cleavage of p35 to p25 by calpain.
Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
[TBL] [Abstract][Full Text] [Related]
4. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
Annamalai B; Won JS; Choi S; Singh I; Singh AK
Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
6. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
7. Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons.
Chen X; Huang T; Zhang J; Song J; Chen L; Zhu Y
Brain Res; 2008 Mar; 1200():99-106. PubMed ID: 18289510
[TBL] [Abstract][Full Text] [Related]
8. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
9. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage.
Sui HJ; Zhang LL; Liu Z; Jin Y
Acta Pharmacol Sin; 2015 May; 36(5):553-64. PubMed ID: 25891085
[TBL] [Abstract][Full Text] [Related]
11. Calpain inhibitor inhibits p35-p25-Cdk5 activation, decreases tau hyperphosphorylation, and improves neurological function after spinal cord hemisection in rats.
Hung KS; Hwang SL; Liang CL; Chen YJ; Lee TH; Liu JK; Howng SL; Wang CH
J Neuropathol Exp Neurol; 2005 Jan; 64(1):15-26. PubMed ID: 15715081
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress.
Feng Q; Cheng B; Yang R; Sun FY; Zhu CQ
Neurosci Lett; 2005 Nov; 388(1):13-6. PubMed ID: 16005567
[TBL] [Abstract][Full Text] [Related]
13. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
Crespo-Biel N; Canudas AM; Camins A; Pallàs M
Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
[TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
15. The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons.
Sinjoanu RC; Kleinschmidt S; Bitner RS; Brioni JD; Moeller A; Ferreira A
Neurochem Int; 2008 Sep; 53(3-4):79-88. PubMed ID: 18590784
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.
Amadoro G; Ciotti MT; Costanzi M; Cestari V; Calissano P; Canu N
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2892-7. PubMed ID: 16477009
[TBL] [Abstract][Full Text] [Related]
17. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
18. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment.
Garg S; Timm T; Mandelkow EM; Mandelkow E; Wang Y
Neurobiol Aging; 2011 Jan; 32(1):1-14. PubMed ID: 20961659
[TBL] [Abstract][Full Text] [Related]
20. Changes in the prefrontal cortex after the hippocampus was injected with Aβ
Wang Y; Sheng H; Zhao J; Guo L; Liu J; Xu J; Liu Q; Huang J; Jiang R; Gan S; Qiu G; Lu W; Xu S; Zhu S
Neurosci Lett; 2021 Jan; 741():135453. PubMed ID: 33186609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
